{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T02:06:02Z","timestamp":1779069962029,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:00:00Z","timestamp":1775865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Liaoning Natural Science Foundation Program","award":["(No.2024-BS-138)"],"award-info":[{"award-number":["(No.2024-BS-138)"]}]},{"name":"Shenyang Science and Technology Bureau Public Health Research and Development Special Project","award":["(No.22-321-34-08)"],"award-info":[{"award-number":["(No.22-321-34-08)"]}]},{"name":"Liaoning Provincial Department of Education General Research Project","award":["(No.LJKMZ20221339)"],"award-info":[{"award-number":["(No.LJKMZ20221339)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Cholestatic liver injury (CLI) has lacked a potent treatment due to its incompletely understood pathogenesis. Saikosaponin D (SSD), the main active ingredient of the traditional Chinese medicine Bupleuri Radix, has significant anti-inflammatory and hepatoprotective effects and inhibits hepatic fibrosis. This study specifically investigated the protective effects of SSD in CLI and its related mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In bile duct ligation (BDL)-induced CLI in mice, the protective effect of SSD was assessed by serum biochemical index analysis, HE staining of liver tissue, Sirius red staining, immunohistochemistry and ELISA. Bile acid-induced human HepG2 cell line was taken to study the protective effect and potential mechanism of SSD against CLI in vitro. TLR4\/MyD88\/NF-\u03baB\/NLRP3 pathway-related proteins in mouse liver tissues or HepG2 cells were detected by Western blot or immunofluorescence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>SSD dose\u2011dependently improved liver function and reduced hepatocyte necrosis, collagen deposition, and apoptosis. It attenuated oxidative stress injury, inflammatory responses, and endoplasmic reticulum stress (ERS) in BDL mice. SSD also mitigated bile acid\u2011induced injury and ERS in HepG2 cells. Moreover, SSD suppressed the activation of the TLR4\/MyD88\/NF\u2011\u03baB\/NLRP3 pathway. The TLR4 inhibitor TAK\u2011242, similar to SSD, ameliorated bile acid\u2011induced HepG2 cell injury and ERS, whereas the TLR4 agonist LPS counteracted the protective effects of SSD and its inhibition of ERS in bile acid\u2011stimulated HepG2 cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SSD attenuates CLI, an effect that may be associated with the suppression of the TLR4\/MyD88\/NF\u2011\u03baB\/NLRP3 pathway and the subsequent inhibition of ERS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-026-00669-8","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T14:08:18Z","timestamp":1775916498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Protective effect of Saikosaponin D modulating endoplasmic reticulum stress mediated by TLR4\/MyD88\/NF-\u03baB\/NLRP3 pathway on cholestatic liver injury"],"prefix":"10.1186","volume":"163","author":[{"given":"XianMeng","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"issue":"5","key":"669_CR1","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.31494","volume":"73","author":"M Frissen","year":"2021","unstructured":"Frissen M, Liao L, Schneider KM, Djudjaj S, Haybaeck J, Wree A, et al. Bidirectional Role of NLRP3 During Acute and Chronic Cholestatic Liver Injury. Hepatology. 2021;73(5):1836\u201354.","journal-title":"Hepatology"},{"issue":"2","key":"669_CR2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jhep.2021.02.035","volume":"75","author":"J Li","year":"2021","unstructured":"Li J, Zhu X, Zhang M, Zhang Y, Ye S, Leng Y, et al. Limb expression 1-like (LIX1L) protein promotes cholestatic liver injury by regulating bile acid metabolism. J Hepatol. 2021;75(2):400\u201313.","journal-title":"J Hepatol"},{"issue":"1","key":"669_CR3","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s42003-024-06243-0","volume":"7","author":"Y Wang","year":"2024","unstructured":"Wang Y, Fu X, Zeng L, Hu Y, Gao R, Xian S, et al. Activation of Nrf2\/HO-1 signaling pathway exacerbates cholestatic liver injury. Commun Biol. 2024;7(1):621.","journal-title":"Commun Biol"},{"key":"669_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-pharmtox-010818-021059","volume":"60","author":"M Wagner","year":"2020","unstructured":"Wagner M, Fickert P. Drug Therapies for Chronic Cholestatic Liver Diseases. Annu Rev Pharmacol Toxicol. 2020;60:503\u201327.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"669_CR5","doi-asserted-by":"crossref","unstructured":"Mazzetti M, Marconi G, Mancinelli M, Benedetti A, Marzioni M, Maroni L. The Management of Cholestatic Liver Diseases: Current Therapies and Emerging New Possibilities. J Clin Med. 2021;10(8):1763.","DOI":"10.3390\/jcm10081763"},{"key":"669_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev-pathol-012513-104649","volume":"10","author":"SA Oakes","year":"2015","unstructured":"Oakes SA, Papa FR. The role of endoplasmic reticulum stress in human pathology. Annu Rev Pathol. 2015;10:173\u201394.","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"669_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41573-021-00320-3","volume":"21","author":"SJ Marciniak","year":"2022","unstructured":"Marciniak SJ, Chambers JE, Ron D. Pharmacological targeting of endoplasmic reticulum stress in disease. Nat Rev Drug Discov. 2022;21(2):115\u201340.","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"669_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","volume":"21","author":"C Hetz","year":"2020","unstructured":"Hetz C, Zhang K, Kaufman RJ. Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol. 2020;21(8):421\u201338.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"669_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.livres.2019.01.002","volume":"3","author":"X Liu","year":"2019","unstructured":"Liu X, Green RM. Endoplasmic reticulum stress and liver diseases. Liver Res. 2019;3(1):55\u201364.","journal-title":"Liver Res"},{"key":"669_CR10","doi-asserted-by":"crossref","unstructured":"Pan PH, Wang YY, Lin SY, Liao SL, Chen YF, Huang WC et al. 18\u03b2-Glycyrrhetinic Acid Protects against Cholestatic Liver Injury in Bile Duct-Ligated Rats. Antioxid (Basel). 2022;11(5):961.","DOI":"10.3390\/antiox11050961"},{"key":"669_CR11","doi-asserted-by":"publisher","first-page":"153889","DOI":"10.1016\/j.tox.2024.153889","volume":"507","author":"RM Mosaoa","year":"2024","unstructured":"Mosaoa RM, Al-Rabia MW, Asfour HZ, Alhakamy NA, Mansouri RA, El-Agamy DS, et al. Targeting SIRT1\/AMPK\/Nrf2\/NF-\u043aB by sitagliptin protects against oxidative stress-mediated ER stress and inflammation during ANIT-induced cholestatic liver injury. Toxicology. 2024;507:153889.","journal-title":"Toxicology"},{"key":"669_CR12","doi-asserted-by":"crossref","unstructured":"Gu S, Zheng Y, Chen C, Liu J, Wang Y, Wang J, Li Y. Research progress on the molecular mechanisms of Saikosaponin D in various diseases (Review). Int J Mol Med. 2025;55(3):37.","DOI":"10.3892\/ijmm.2024.5478"},{"key":"669_CR13","doi-asserted-by":"publisher","first-page":"205873842095059","DOI":"10.1177\/2058738420950593","volume":"34","author":"Y Chen","year":"2020","unstructured":"Chen Y, Que R, Lin L, Shen Y, Liu J, Li Y. Inhibition of oxidative stress and NLRP3 inflammasome by Saikosaponin-d alleviates acute liver injury in carbon tetrachloride-induced hepatitis in mice. Int J Immunopathol Pharmacol. 2020;34:2058738420950593.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"669_CR14","doi-asserted-by":"publisher","first-page":"894981","DOI":"10.3389\/fphar.2022.894981","volume":"13","author":"K Zhang","year":"2022","unstructured":"Zhang K, Lin L, Zhu Y, Zhang N, Zhou M, Li Y. Saikosaponin d Alleviates Liver Fibrosis by Negatively Regulating the ROS\/NLRP3 Inflammasome Through Activating the ER\u03b2 Pathway. Front Pharmacol. 2022;13:894981.","journal-title":"Front Pharmacol"},{"issue":"10","key":"669_CR15","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/s41401-020-00597-x","volume":"42","author":"SN Chen","year":"2021","unstructured":"Chen SN, Tan Y, Xiao XC, Li Q, Wu Q, Peng YY, et al. Deletion of TLR4 attenuates lipopolysaccharide-induced acute liver injury by inhibiting inflammation and apoptosis. Acta Pharmacol Sin. 2021;42(10):1610\u20139.","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"669_CR16","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1007\/s11596-021-2364-8","volume":"41","author":"SH Zhang","year":"2021","unstructured":"Zhang SH, Yu MJ, Yan JL, Xiao JH, Xiao Y, Yang JL, et al. TLR4 Knockout Attenuates BDL-induced Liver Cholestatic Injury through Amino Acid and Choline Metabolic Pathways. Curr Med Sci. 2021;41(3):572\u201380.","journal-title":"Curr Med Sci"},{"key":"669_CR17","doi-asserted-by":"publisher","first-page":"106181","DOI":"10.1016\/j.intimp.2019.106181","volume":"80","author":"J Su","year":"2020","unstructured":"Su J, Pan YW, Wang SQ, Li XZ, Huang F, Ma SP. Saikosaponin-d attenuated lipopolysaccharide-induced depressive-like behaviors via inhibiting microglia activation and neuroinflammation. Int Immunopharmacol. 2020;80:106181.","journal-title":"Int Immunopharmacol"},{"key":"669_CR18","doi-asserted-by":"publisher","first-page":"116729","DOI":"10.1016\/j.jep.2023.116729","volume":"316","author":"X Wang","year":"2023","unstructured":"Wang X, Li S, Yu J, Wang W, Du Z, Gao S, et al. Saikosaponin B2 ameliorates depression-induced microglia activation by inhibiting ferroptosis-mediated neuroinflammation and ER stress. J Ethnopharmacol. 2023;316:116729.","journal-title":"J Ethnopharmacol"},{"issue":"15","key":"669_CR19","first-page":"6956","volume":"27","author":"XL Liu","year":"2023","unstructured":"Liu XL, Fan L, Yue BH, Lou Z. Saikosaponin A mitigates the progression of Parkinson\u2019s disease via attenuating microglial neuroinflammation through TLR4\/MyD88\/NF-\u03baB pathway. Eur Rev Med Pharmacol Sci. 2023;27(15):6956\u201371.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"669_CR20","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1038\/s41467-023-40081-8","volume":"14","author":"Y Bai","year":"2023","unstructured":"Bai Y, Li K, Li X, Chen X, Zheng J, Wu F, et al. Effects of oxidative stress on hepatic encephalopathy pathogenesis in mice. Nat Commun. 2023;14(1):4456.","journal-title":"Nat Commun"},{"key":"669_CR21","doi-asserted-by":"crossref","unstructured":"Chang GR, Lin WL, Lin TC, Liao HJ, Lu YW. The Ameliorative Effects of Saikosaponin in Thioacetamide-Induced Liver Injury and Non-Alcoholic Fatty Liver Disease in Mice. Int J Mol Sci. 2021;22(21):11383.","DOI":"10.3390\/ijms222111383"},{"issue":"3","key":"669_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s12276-022-00737-9","volume":"54","author":"D Han","year":"2022","unstructured":"Han D, Kim H, Kim S, Le QA, Han SY, Bae J, et al. Sestrin2 protects against cholestatic liver injury by inhibiting endoplasmic reticulum stress and NLRP3 inflammasome-mediated pyroptosis. Exp Mol Med. 2022;54(3):239\u201351.","journal-title":"Exp Mol Med"},{"key":"669_CR23","doi-asserted-by":"publisher","first-page":"113133","DOI":"10.1016\/j.biopha.2022.113133","volume":"151","author":"PH Pan","year":"2022","unstructured":"Pan PH, Wang YY, Lin SY, Liao SL, Chen YF, Huang WC, et al. Plumbagin ameliorates bile duct ligation-induced cholestatic liver injury in rats. Biomed Pharmacother. 2022;151:113133.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"669_CR24","doi-asserted-by":"publisher","first-page":"16756","DOI":"10.1038\/s41598-024-67882-1","volume":"14","author":"Z Hu","year":"2024","unstructured":"Hu Z, Cheng X, Cai J, Huang C, Hu J, Liu J. Emodin alleviates cholestatic liver injury by modulating Sirt1\/Fxr signaling pathways. Sci Rep. 2024;14(1):16756.","journal-title":"Sci Rep"},{"issue":"4","key":"669_CR25","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/HEP.0000000000000611","volume":"79","author":"Y Zhuang","year":"2024","unstructured":"Zhuang Y, Ortega-Ribera M, Thevkar Nagesh P, Joshi R, Huang H, Wang Y, et al. Bile acid-induced IRF3 phosphorylation mediates cell death, inflammatory responses, and fibrosis in cholestasis-induced liver and kidney injury via regulation of ZBP1. Hepatology. 2024;79(4):752\u201367.","journal-title":"Hepatology"},{"issue":"8","key":"669_CR26","doi-asserted-by":"publisher","first-page":"737","DOI":"10.21037\/atm-20-5110","volume":"9","author":"SY Cai","year":"2021","unstructured":"Cai SY, Boyer JL. The role of bile acids in cholestatic liver injury. Ann Transl Med. 2021;9(8):737.","journal-title":"Ann Transl Med"},{"issue":"1","key":"669_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00018-015-2052-6","volume":"73","author":"DS Schwarz","year":"2016","unstructured":"Schwarz DS, Blower MD. The endoplasmic reticulum: structure, function and response to cellular signaling. Cell Mol Life Sci. 2016;73(1):79\u201394.","journal-title":"Cell Mol Life Sci"},{"issue":"7586","key":"669_CR28","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nature17041","volume":"529","author":"M Wang","year":"2016","unstructured":"Wang M, Kaufman RJ. Protein misfolding in the endoplasmic reticulum as a conduit to human disease. Nature. 2016;529(7586):326\u201335.","journal-title":"Nature"},{"issue":"9","key":"669_CR29","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1080\/15548627.2020.1827780","volume":"17","author":"S Zielke","year":"2021","unstructured":"Zielke S, Kardo S, Zein L, Mari M, Covarrubias-Pinto A, Kinzler MN, et al. ATF4 links ER stress with reticulophagy in glioblastoma cells. Autophagy. 2021;17(9):2432\u201348.","journal-title":"Autophagy"},{"issue":"12","key":"669_CR30","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/s41419-022-05444-x","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang J, Guo J, Yang N, Huang Y, Hu T, Rao C. Endoplasmic reticulum stress-mediated cell death in liver injury. Cell Death Dis. 2022;13(12):1051.","journal-title":"Cell Death Dis"},{"key":"669_CR31","doi-asserted-by":"crossref","unstructured":"Lee D, Park JS, Kim D, Hong HS. Substance P Hinders Bile Acid-Induced Hepatocellular Injury by Modulating Oxidative Stress and Inflammation. Antioxid (Basel). 2022;11(5):920.","DOI":"10.3390\/antiox11050920"},{"issue":"3","key":"669_CR32","doi-asserted-by":"publisher","first-page":"e14481","DOI":"10.1111\/cbdd.14481","volume":"103","author":"JY Liu","year":"2024","unstructured":"Liu JY, Shen YL, Zhu JY, Yang DD. Saikosaponin D mitigate pilocarpine-induced astrocyte injury by regulating the NLRP3\/caspase-1 signaling pathway. Chem Biol Drug Des. 2024;103(3):e14481.","journal-title":"Chem Biol Drug Des"},{"key":"669_CR33","doi-asserted-by":"crossref","unstructured":"Peng D, Chen Y, Sun Y, Zhang Z, Cui N, Zhang W et al. Saikosaponin A and Its Epimers Alleviate LPS-Induced Acute Lung Injury in Mice. Molecules. 2023;28(3):967.","DOI":"10.3390\/molecules28030967"},{"key":"669_CR34","doi-asserted-by":"crossref","unstructured":"Wang T, Wang M, Liu W, Zhang L, Zhang J, Zhao J et al. Intracellular CIRP promotes liver regeneration via STAT3 signaling pathway activation after partial hepatectomy in mice. Int J Mol Med. 2025;55(3):42.","DOI":"10.3892\/ijmm.2025.5483"},{"issue":"1","key":"669_CR35","doi-asserted-by":"publisher","first-page":"166889","DOI":"10.1016\/j.bbadis.2023.166889","volume":"1870","author":"R Wang","year":"2024","unstructured":"Wang R, Feng W, Wang Y, Jiang Y, Lin Y, Chen X. Maternal obstructive sleep apnea aggravates metabolic dysfunction-associated fatty liver disease via HMGB1-TLR4 signaling-mediated endoplasmic reticulum stress in male offspring rats. Biochim Biophys Acta Mol Basis Dis. 2024;1870(1):166889.","journal-title":"Biochim Biophys Acta Mol Basis Dis"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-026-00669-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00669-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00669-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T01:10:55Z","timestamp":1779066655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41065-026-00669-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["669"],"URL":"https:\/\/doi.org\/10.1186\/s41065-026-00669-8","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were complied with the ARRIVE guidelines and performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The experiments were approved by the Institutional Animal Care and Use Committee of Liaoning University of Traditional Chinese Medicine (No.2022-LN193).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}